The role of surgery and ablative radiotherapy in oligometastatic breast cancer

Seminars in Oncology

Volumn 41, Issue 6, 2014, Pages 790-797

  Salama, Joseph K ^a   Chmura, Steven J ^b,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Ludwig Center for Metastasis Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; ABLATIVE RADIOTHERAPY; ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CLINICAL TRIAL (TOPIC); HUMAN; IMAGE GUIDED RADIOTHERAPY; OLIGOMETASTATIC BREAST CANCER; OVERALL SURVIVAL; PATIENT SELECTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT OUTCOME; BREAST NEOPLASMS; FEMALE; MULTIMODALITY CANCER THERAPY; PROCEDURES; PROGNOSIS; RADIOSURGERY; RADIOTHERAPY; SECONDARY;

BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; PROGNOSIS; RADIOSURGERY; RADIOTHERAPY;

EID: 84920663305     PISSN: 00937754     EISSN: 15328708     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2014.09.016     Document Type: Article

References (59)

1. D.M. Macdermed, R.R. Weichselbaum, and J.K. Salama A rationale for the targeted treatment of oligometastases with radiotherapy J Surg Oncol 98 2008 202 206
2. B.A. Pockaj, N. Wasif, and A.C. Dueck Metastasectomy and surgical resection of the primary tumor in patients with stage IV breast cancer: time for a second look? Ann Surg Oncol 17 2010 2419 2426
3. W. Halstead The results of radical operations for the cure of carcinoma of the breast Ann Surg 46 1907 1 19
4. B. Fisher Laboratory and clinical research in breast cancer - a personal adventure: the David A. Karnofsky memorial lecture Cancer Res 40 1980 3863 3874
5. S. Hellman Karnofsky Memorial Lecture. Natural history of small breast cancers J Clin Oncol 12 1994 2229 2234
6. S. Hellman, and R.R. Weichselbaum Oligometastases J Clin Oncol 13 1995 8 10
7. J.A. van Dongen, and E.A. van Slooten The surgical treatment of pulmonary metastases Cancer Treat Rev 5 1978 29 48
8. J. Alexander, and C. Haight Pulmonary resction for solitary metastatic sarcomas and carcinomas Surg Gynecol Obstet 85 1947 129 146
9. P.L. Dorn, A. Meriwether, and M. LeMieux Patterns of distant failure and progression in breast cancer: implications for the treatment of oligometastatic disease Int J Radiat Oncol Biol Phys 81 2011 S643
10. G.N. Hortobagyi, T.L. Smith, and S.S. Legha Multivariate analysis of prognostic factors in metastatic breast cancer J Clin Oncol 1 1983 776 786
11. P.A. Greenberg, G.N. Hortobagyi, and T.L. Smith Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer J Clin Oncol 14 1996 2197 2205
12. N. Yamamoto, N. Katsumata, and T. Watanabe Clinical characteristics of patients with metastatic breast cancer with complete remission following systemic treatment Jpn J Clin Oncol 28 1998 368 373
13. E. Tomiak, M. Piccart, and F. Mignolet Characterisation of complete responders to combination chemotherapy for advanced breast cancer: a retrospective EORTC Breast Group study Eur J Cancer 32A 1996 1876 1887
14. Y. Fong, M.F. Brennan, and A.M. Cohen Liver resection in the elderly Br J Surg 84 1997 1386 1390
15. K.E. Rusthoven, B.D. Kavanagh, and S.H. Burri Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases J Clin Oncol 27 2009 1579 1584
16. K.E. Rusthoven, B.D. Kavanagh, and H. Cardenes Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases J Clin Oncol 27 2009 1572 1578
17. Y. Fong, A.M. Cohen, and J.G. Fortner Liver resection for colorectal metastases J Clin Oncol 15 1997 938 946
18. M. Wronski, E. Arbit, and M. Burt Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991 J Neurosurg 83 1995 605 616
19. M. Kocher, R. Soffietti, and U. Abacioglu Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study J Clin Oncol 29 2011 134 141
20. T. Tanvetyanon, L.A. Robinson, and M.J. Schell Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis J Clin Oncol 26 2008 1142 1147
21. J. Torok, R.E. Wegner, and S.A. Burton Stereotactic body radiation therapy for adrenal metastases: a retrospective review of a noninvasive therapeutic strategy Future Oncol 7 2011 145 151
22. M.T. Milano, A.W. Katz, and H. Zhang Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study Int J Radiat Oncol Biol Phys 83 2012 878 886
23. J.K. Salama, J.P. Kirkpatrick, and F.F. Yin Stereotactic body radiotherapy treatment of extracranial metastases Nat Rev Clin Oncol 9 2012 654 665
24. C.C. Tong, E.C. Ko, and M.W. Sung Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases PLoS One 7 2012 e36979
25. G. Friedel, U. Pastorino, and R.J. Ginsberg Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases Eur J Cardiothor Surg 22 2002 335 344
26. J.P. Kirkpatrick, C.R. Kelsey, and M. Palta Stereotactic body radiotherapy: a critical review for non-radiation oncologists Cancer 120 7 2014 942 954
27. Z. Fuks, and R. Kolesnick Engaging the vascular component of the tumor response Cancer Cell 8 2005 89 91
28. M. Garcia-Barros, F. Paris, and C. Cordon-Cardo Tumor response to radiotherapy regulated by endothelial cell apoptosis Science 300 2003 1155 1159
29. Y. Lee, S.L. Auh, and Y. Wang Therapeutic effects of ablative radiation on local tumor require CD8+T cells: changing strategies for cancer treatment Blood 114 2009 589 595
30. H. Liang, L. Deng, and S. Chmura Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing J Immunol 190 2013 5874 5881
31. R. McCammon, T.E. Schefter, and L.E. Gaspar Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy Int J Radiat Oncol Biol Phys 73 2009 112 118
32. K. Corbin, M. Ranck, and M. Hasselle Feasibility and toxicity of hypofractionated image-guided radiotherapy for large volume limited metastatic disease Pract Radiat Oncol 3 4 2013 316 322
33. K.L. Blackwell, H.J. Burstein, and A.M. Storniolo Overall survival benefit with lapatinib in combination with trastuzumab for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: final results from the EGF104900 Study J Clin Oncol 30 2012 2585 2592
34. J.K. Salama, M.D. Hasselle, and S.J. Chmura Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease Cancer 118 2012 2962 2970
35. M.T. Milano, H. Zhang, and S.K. Metcalfe Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy Breast Cancer Res Treat 115 2009 601 608
36. N. Mehta, A.M. Mauer, and S. Hellman Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment Int J Oncol 25 2004 1677 1683
37. S. Formenti, K. Friedman, and K. Chao Abscopal response in irradiated patients: results of a proof of priniciple trial Int J Radiat Oncol Biol Phys 72 2008 S6 S7
38. A. Sahgal, D.A. Larson, and E.L. Chang Stereotactic body radiosurgery for spinal metastases: a critical review Int J Radiat Oncol Biol Phys 71 2008 652 665
39. J.A. Forquer, A.J. Fakiris, and R.D. Timmerman Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites Radiother Oncol 93 2009 408 413
40. B.S. Hoppe, B. Laser, and A.V. Kowalski Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk? Int J Radiat Oncol Biol Phys 72 2008 1283 1286
41. A. Sahgal, V. Weinberg, and L. Ma Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice Int J Radiat Oncol Biol Phys 85 2013 341 347
42. A. Sahgal, E.G. Atenafu, and S. Chao Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score J Clin Oncol 31 2013 3426 3431
43. Lewis S, Porceddu S, Nakamura N, et al. Definitive stereotactic body radiotherapy (SBRT) for extracranial oligometastases: an international survey of>1000 radiation oncologists. Am J Clin Oncol. In press.
44. A.C. Tree, V.S. Khoo, and R.A. Eeles Stereotactic body radiotherapy for oligometastases Lancet Oncol 14 2013 e28 e37
45. D.A. Palma, C.J. Haasbeek, and G.B. Rodrigues Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial BMC Cancer 12 2012 305
46. T. Treasure Oligometastatic cancer: an entity, a useful concept, or a therapeutic opportunity? J R Soc Med 105 2012 242 246
47. D.E. Abbott, A. Brouquet, and E.A. Mittendorf Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome Surgery 151 2012 710 716
48. Y. Fong, J. Fortner, and R.L. Sun Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 1999 309 318
49. T. de Vin, B. Engels, and T. Gevaert Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival Ann Oncol 25 2014 467 471
50. Y.A. Lussier, H.R. Xing, and J.K. Salama MicroRNA expression characterizes oligometastasis(es) PloS One 6 2011 e28650
51. Y.A. Lussier, N.N. Khodarev, and K. Regan Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs PLoS One 7 2012 e50141
52. A.A. Solanki, R.R. Weichselbaum, and D. Appelbaum The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study Radiat Oncol 7 2012 216
53. M. Cristofanilli, G.T. Budd, and M.J. Ellis Circulating tumor cells, disease progression, and survival in metastatic breast cancer N Engl J Med 351 2004 781 791
54. K.S. Albain Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment J Clin Oncol 26 24 2008 3950
55. J. Bergh Clinical and pharmacokinetic study of sunitinib and docetaxel in women with advanced breast cancer Breast 21 4 2012 507 513
56. H. Tawfik, Y. Rostom, and H. Elghazaly All-oral combination of vinorelbine and capecitabine as first-line treatment in HER2/Neu-negative metastatic breast cancer Cancer Chemother Pharmacol 71 4 2013 913 919
57. S.A. Hurvitz A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy Breast Cancer Res Treat 141 3 2013 437 446
58. L. Gianni AVEREL: a randomized phase III trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer J Clin Oncol 31 14 2013 1719 1725
59. G.W. Sledge, D. Neuberg, and P. Bernardo Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193) J Clin Oncol 21 4 2003 588 592